Citation Impact
Citing Papers
Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis
2013
Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States
2016
Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology
2015
Changes in Utilization and Discard of Hepatitis C–Infected Donor Livers in the Recent Era
2016
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery
2012 Standout
Obstructive Sleep Apnea Is Associated with Fatty Liver and Abnormal Liver Enzymes: a Meta-analysis
2013
Hepatic Expression of CXC Chemokines Predicts Portal Hypertension and Survival in Patients With Alcoholic Hepatitis
2009
Reversion of disease manifestations after HCV eradication
2016
Treating hepatitis C infection in liver transplant recipients
2006
Role of gastric sensorimotor dysfunction in gastrointestinal symptoms and energy intake in liver cirrhosis
2006
In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis
2011
Hepatitis C and liver transplantation
2005 Nature
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Role of Antioxidants and Natural Products in Inflammation
2016 Standout
Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis
2017
Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation
2009
mixOmics: An R package for ‘omics feature selection and multiple data integration
2017 Standout
Burden of liver diseases in the world
2018 Standout
Mechanisms of Environmental Contributions to Fatty Liver Disease
2019
Nutrition for the liver transplant patient
2006
Hepatic inflammation and progressive liver fibrosis in chronic liver disease
2014
Interleukin-22 Treatment Ameliorates Alcoholic Liver Injury in a Murine Model of Chronic-Binge Ethanol Feeding: Role of Signal Transducer and Activator of Transcription 3
2010
Alcoholic liver disease: mechanisms of injury and targeted treatment
2015
Acute-on chronic liver failure
2012
Diagnosis and Management of Autoimmune Hepatitis
2010
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Adjuvant Nutrition Management of Patients with Liver Failure, Including Transplant
2011
Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection
2016
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Safety and Efficacy of Treatment of Hepatitis C in Kidney Transplant Recipients With Directly Acting Antiviral Agents
2016
Gastrointestinal tract in liver disease: which organ is sick?
2008
Immunotherapy for hepatocellular carcinoma
2019
The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma
2016
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Antiviral treatment of hepatitis C
2014
Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines
2019
Pentoxifylline Does Not Decrease Short-term Mortality but Does Reduce Complications in Patients With Advanced Cirrhosis
2010
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Mechanisms and cell signaling in alcoholic liver disease
2010
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees
2012
Pre- and Post-Transplant Antiviral Therapy (HBV, HCV)
2016
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness
2014 StandoutNobel
Pyroptosis: mechanisms and diseases
2021 Standout
Pros and Cons: Usage of organs from donors infected with hepatitis C virus – Revision in the direct-acting antiviral era
2015
Treating hepatitis C
2005 StandoutNobel
Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications
2011
Treatment of hepatitis C in difficult-to-treat patients
2015
Intestinal permeability in cirrhotic patients with and without ascites
2005
Sarcopenia
2019 Standout
Global burden of liver disease: 2023 update
2023 Standout
Frailty: implications for clinical practice and public health
2019 Standout
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Increased intestinal permeability in malnourished patients with liver cirrhosis
2012
Gastrointestinal symptoms in patients with liver cirrhosis: Associations with nutritional status and health-related quality of life
2006
Hepatitis C Virus: 30 Years after Its Discovery
2019 StandoutNobel
Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)
2019
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
The N-terminal Helical Region of the Hepatitis C Virus p7 Ion Channel Protein Is Critical for Infectious Virus Production
2015 StandoutNobel
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Roles of gender and obesity in defining correlations between perfluoroalkyl substances and lipid/lipoproteins
2018
Gastrointestinal dysfunction in liver cirrhosis
2014
Translating an Understanding of the Pathogenesis of Hepatic Fibrosis to Novel Therapies
2013
Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation
2014
A Prospective Evaluation of Fibrosis Progression in Patients with Recurrent Hepatitis C Virus Following Liver Transplantation†
2007
Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation
2005
Infection in Patients With Severe Alcoholic Hepatitis Treated With Steroids: Early Response to Therapy Is the Key Factor
2009
NAFLD: A multisystem disease
2015 Standout
Alcoholic Liver Disease
2009
Drug therapy for ulcerative colitis
2004
Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis
2010
Curcumin Maintenance Therapy for Ulcerative Colitis: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
2006 Standout
Alcoholic steatohepatitis
2010
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Association of obstructive sleep apnoea with the presence and severity of non‐alcoholic fatty liver disease. A systematic review and meta‐analysis
2013
Gut Microbiota in Health and Disease
2010 Standout
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Muscle Wasting Is Associated With Mortality in Patients With Cirrhosis
2011
Recombinant Hepatitis C Virus Envelope Glycoprotein Vaccine Elicits Antibodies Targeting Multiple Epitopes on the Envelope Glycoproteins Associated with Broad Cross-Neutralization
2014 StandoutNobel
Adverse events associated with ERCP
2016 Standout
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
2014 StandoutNobel
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Alcoholic Hepatitis
2009
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
2021
Identification of Rodent Homologs of Hepatitis C Virus and Pegiviruses
2013 StandoutNobel
Pancreatic and biliary stents
2013
Treatment of alcoholic liver disease
2010
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
Antibiotic perturbation of the murine gut microbiome enhances the adiposity, insulin resistance, and liver disease associated with high-fat diet
2016
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
2017 Standout
Role of Nutrition in the Management of Hepatic Encephalopathy in End-Stage Liver Failure
2010
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting
2016
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Towards a small animal model for hepatitis C
2009 StandoutNobel
Both sarcopenia and frailty determine suitability of patients for liver transplantation—A systematic review and meta‐analysis of the literature
2018
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Current status of novel antifibrotic therapies in patients with chronic liver disease
2011
Works of Bashar Aqel being referenced
Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis
2015
Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C1
2004
Endoscopic treatment of anastomotic biliary strictures after living donor liver transplantation: outcomes after maximal stent therapy
2012
CASE REPORT: Collagenous Colitis Evolving into Ulcerative Colitis: A Case Report and Review of the Literature
2003
Natural History of Post-Liver Transplantation Hepatitis C
2009
Nuclear receptors and nonalcoholic fatty liver disease
2016
Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation
2013
Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease
2015
Six-minute walk distance predicts mortality in liver transplant candidates
2010
Efficacy of Tacrolimus in the Treatment of Steroid Refractory Autoimmune Hepatitis
2004
A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis
2008
Contribution of Ascites to Impaired Gastric Function and Nutritional Intake in Patients With Cirrhosis and Ascites
2005
498 NATURAL HISTORY OF HEPATITIS C AFTER LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
2009
Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience
2018
Relationship between sarcopenia, six‐minute walk distance and health‐related quality of life in liver transplant candidates
2014
Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant
2015
Evidence for liver injury in the setting of obstructive sleep apnea
2012